178 related articles for article (PubMed ID: 25789047)
1. Promoter methylation and expression changes of
Li Q; Wei W; Jiang YI; Yang H; Liu J
Oncol Lett; 2015 Apr; 9(4):1807-1813. PubMed ID: 25789047
[No Abstract] [Full Text] [Related]
2. Promoter Hypermethylation and Expression Changes of BRCA1 Gene in a Cohort of Sporadic Breast Cancer Cases among Pakistani Population.
Arif T; Anwar N
Asian Pac J Cancer Prev; 2020 Aug; 21(8):2395-2401. PubMed ID: 32856871
[TBL] [Abstract][Full Text] [Related]
3. Frequent epigenetic inactivation of RSK4 by promoter methylation in cancerous and non-cancerous tissues of breast cancer.
Li Q; Jiang Y; Wei W; Ji Y; Gao H; Liu J
Med Oncol; 2014 Jan; 31(1):793. PubMed ID: 24338215
[TBL] [Abstract][Full Text] [Related]
4. Aberrant methylation of the BRCA1 CpG island promoter is associated with decreased BRCA1 mRNA in sporadic breast cancer cells.
Rice JC; Massey-Brown KS; Futscher BW
Oncogene; 1998 Oct; 17(14):1807-12. PubMed ID: 9778046
[TBL] [Abstract][Full Text] [Related]
5. BRCA1 Promoter Methylation and Clinicopathological Characteristics in Sporadic Breast Cancer Patients in Indonesia.
Harahap WA; Sudji IR; Nindrea RD
Asian Pac J Cancer Prev; 2018 Sep; 19(9):2643-2649. PubMed ID: 30256562
[TBL] [Abstract][Full Text] [Related]
6. Methylation profiles of the BRCA1 promoter in hereditary and sporadic breast cancer among Han Chinese.
Pang D; Zhao Y; Xue W; Shan M; Chen Y; Zhang Y; Zhang G; Liu F; Li D; Yang Y
Med Oncol; 2012 Sep; 29(3):1561-8. PubMed ID: 22076508
[TBL] [Abstract][Full Text] [Related]
7. BRCA promoter methylation in sporadic versus BRCA germline mutation-related breast cancers.
Vos S; Moelans CB; van Diest PJ
Breast Cancer Res; 2017 May; 19(1):64. PubMed ID: 28569220
[TBL] [Abstract][Full Text] [Related]
8. Promoter hypermethylation and post-transcriptional mechanisms for reduced BRCA1 immunoreactivity in sporadic human breast cancers.
Miyamoto K; Fukutomi T; Asada K; Wakazono K; Tsuda H; Asahara T; Sugimura T; Ushijima T
Jpn J Clin Oncol; 2002 Mar; 32(3):79-84. PubMed ID: 11956301
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic Inactivation of BRCA1 Through Promoter Hypermethylation and Its Clinical Importance in Triple-Negative Breast Cancer.
Yamashita N; Tokunaga E; Kitao H; Hitchins M; Inoue Y; Tanaka K; Hisamatsu Y; Taketani K; Akiyoshi S; Okada S; Oda Y; Saeki H; Oki E; Maehara Y
Clin Breast Cancer; 2015 Dec; 15(6):498-504. PubMed ID: 26195437
[TBL] [Abstract][Full Text] [Related]
10. Investigation of DNA damage response and apoptotic gene methylation pattern in sporadic breast tumors using high throughput quantitative DNA methylation analysis technology.
Pal R; Srivastava N; Chopra R; Gochhait S; Gupta P; Prakash N; Agarwal G; Bamezai RN
Mol Cancer; 2010 Nov; 9():303. PubMed ID: 21092294
[TBL] [Abstract][Full Text] [Related]
11. Methylation of the BRCA1 promoter is associated with decreased BRCA1 mRNA levels in clinical breast cancer specimens.
Rice JC; Ozcelik H; Maxeiner P; Andrulis I; Futscher BW
Carcinogenesis; 2000 Sep; 21(9):1761-5. PubMed ID: 10964110
[TBL] [Abstract][Full Text] [Related]
12. BRCA1 methylation in breast duct carcinoma, a practical study in Duhok-Iraq.
Hasan NA; Pity IS
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):34-39. PubMed ID: 38279496
[TBL] [Abstract][Full Text] [Related]
13. Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer.
Potapova A; Hoffman AM; Godwin AK; Al-Saleem T; Cairns P
Cancer Res; 2008 Feb; 68(4):998-1002. PubMed ID: 18281473
[TBL] [Abstract][Full Text] [Related]
14. Association of BRCA1 promoter methylation with rs11655505 (c.2265C>T) variants and decreased gene expression in sporadic breast cancer.
Hasan TN; Leena Grace B; Shafi G; Syed R
Clin Transl Oncol; 2013 Jul; 15(7):555-62. PubMed ID: 23263908
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients.
Sharma G; Mirza S; Parshad R; Srivastava A; Gupta SD; Pandya P; Ralhan R
Life Sci; 2010 Jul; 87(3-4):83-91. PubMed ID: 20470789
[TBL] [Abstract][Full Text] [Related]
16. Hypermethylation of BRCA1 gene: implication for prognostic biomarker and therapeutic target in sporadic primary triple-negative breast cancer.
Zhu X; Shan L; Wang F; Wang J; Wang F; Shen G; Liu X; Wang B; Yuan Y; Ying J; Yang H
Breast Cancer Res Treat; 2015 Apr; 150(3):479-86. PubMed ID: 25783183
[TBL] [Abstract][Full Text] [Related]
17. Association of BRCA1 promoter methylation with sporadic breast cancers: Evidence from 40 studies.
Zhang L; Long X
Sci Rep; 2015 Dec; 5():17869. PubMed ID: 26643130
[TBL] [Abstract][Full Text] [Related]
18.
Bai X; Fu Y; Xue H; Guo K; Song Z; Yu Z; Jia T; Yan Y; Zhao L; Mi X; Wang E; Zheng Z; Zhao H; Yao W; Wei M
Oncol Lett; 2014 Apr; 7(4):1088-1096. PubMed ID: 24944674
[TBL] [Abstract][Full Text] [Related]
19. Mutational, epigenetic and expressional analyses of caveolin-1 gene in breast cancers.
Chen ST; Lin SY; Yeh KT; Kuo SJ; Chan WL; Chu YP; Chang JG
Int J Mol Med; 2004 Oct; 14(4):577-82. PubMed ID: 15375584
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological significance of BRCA1 promoter hypermethylation in Thai breast cancer patients.
Saelee P; Chaiwerawattana A; Ogawa K; Cho YM; Tiwawech D; Suktangman V
Asian Pac J Cancer Prev; 2014; 15(24):10585-9. PubMed ID: 25605143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
